西藏药业: 西藏诺迪康药业股份有限公司关于召开2025年第一次临时股东大会的提示性公告

Group 1 - The company will hold its first extraordinary general meeting of shareholders in 2025 on September 2, 2025 [1][2] - The meeting will be conducted using a combination of on-site and online voting methods [1][3] - The on-site meeting will take place at 14:30 on September 2, 2025, at the company's office in Chengdu, Sichuan Province [1][2] Group 2 - The online voting system will be provided by the Shanghai Stock Exchange, with voting available from 9:15 to 15:00 on the day of the meeting [2][3] - Shareholders must complete identity verification to vote via the internet for the first time [3][4] - The company will utilize a reminder service to ensure that small and medium-sized investors are informed about the meeting and can participate [4] Group 3 - Only shareholders registered by the close of trading on August 27, 2025, will be eligible to attend the meeting [5][6] - Shareholders can appoint a proxy to attend and vote on their behalf, and the proxy does not need to be a shareholder [5][6] - The company has provided contact information for inquiries related to the meeting [6]